These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14758778)

  • 1. Diquafosol tetrasodium. Inspire/Allergan/Santen.
    Fischbarg J
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1377-83. PubMed ID: 14758778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diquafosol: DE 089, diquafosol tetrasodium, INS 365, INS 365 Ophthalmic, INS 365 Respiratory, KPY 998.
    Drugs R D; 2003; 4(6):359-62. PubMed ID: 14584965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diquafosol tetrasodium: a novel dry eye therapy.
    Nichols KK; Yerxa B; Kellerman DJ
    Expert Opin Investig Drugs; 2004 Jan; 13(1):47-54. PubMed ID: 14680452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diquafosol ophthalmic solution for dry eye treatment.
    Nakamura M; Imanaka T; Sakamoto A
    Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.
    Bremond-Gignac D; Gicquel JJ; Chiambaretta F
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):905-13. PubMed ID: 24797483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye.
    Kaido M; Uchino M; Kojima T; Dogru M; Tsubota K
    J Ocul Pharmacol Ther; 2013; 29(6):595-603. PubMed ID: 23537148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
    Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
    Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
    Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
    Utsunomiya T; Kawahara A; Hanada K; Yoshida A
    Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecule of the month. Diquafosol tetrasodium.
    Drug News Perspect; 2003 Oct; 16(8):539. PubMed ID: 14668951
    [No Abstract]   [Full Text] [Related]  

  • 11. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
    Jeon HS; Hyon JY
    J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis.
    Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S
    Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
    Keating GM
    Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Topical 3% Diquafosol Ophthalmic Solution for the Treatment of Multifactorial Dry Eye Disease: Meta-Analysis of Randomized Clinical Trials.
    Nam K; Kim HJ; Yoo A
    Ophthalmic Res; 2019; 61(4):188-198. PubMed ID: 30654362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diquafosol Sodium Inhibits Apoptosis and Inflammation of Corneal Epithelial Cells Via Activation of Erk1/2 and RSK: In Vitro and In Vivo Dry Eye Model.
    Park JH; Moon SH; Kang DH; Um HJ; Kang SS; Kim JY; Tchah H
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5108-5115. PubMed ID: 30372737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
    Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
    Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study.
    Ohashi Y; Munesue M; Shimazaki J; Takamura E; Yokoi N; Watanabe H; Nomura A; Shimada F
    Adv Ther; 2020 Feb; 37(2):707-717. PubMed ID: 31834617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye.
    Koh S; Ikeda C; Takai Y; Watanabe H; Maeda N; Nishida K
    Jpn J Ophthalmol; 2013 Sep; 57(5):440-6. PubMed ID: 23740285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
    Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L
    Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.